Articles

Jarvik Heart Inc. announced conditional U.S. Food and Drug Administration (FDA) approval of its pivotal trial for evaluation of the Jarvik 2000 heart for destination therapy (DT). Use of the...

SynCardia Total Artificial Heart patient Jack Miller was able to enjoy Christmas

Jack Miller, 62, is probably the only politician in America who smiles when people call him “heartless.” Four months ago, doctors at Virginia Commonwealth University (VCU) Medical Center in...

The Holy Grail sought for more than two decades by interventional cardiology has been proof that minimally invasive, percutaneous coronary interventions (PCI) procedures can perform as well or...

Abbott began enrolling U.S. patients in the EXCEL trial, which will compare the use of the Xience Prime or Xience V drug-eluting strents to coronary artery bypass graft (CABG) surgery for...

The space needed and costs involved to create a hybrid operating room (OR) for a specific speciality may not be feasible, especially at mid-sized hospitals. This was the case at Middlesex Hospital...

One of the biggest trends is the creation of hybrid operating rooms (ORs) that bring together the best of both surgical and interventional technologies. They are centered around a high-quality...

September 1, 2011 – Mechanical pumps to give failing hearts a boost were originally developed as temporary measures for patients awaiting a heart transplant. But as the technology has improved,...

August 30, 2011 – Results from a study presented at the European Society of Cardiology (ESC) Congress 2011 show that transcatheter aortic-valve implantation (TAVI) in low-risk patients met...

April 8, 2011 – In the largest randomized, multicenter trial to compare drug-eluting stents (DES) and bare-metal stents (BMS) placed in saphenous vein graft lesions, researchers found that DES led...

April 8, 2011 – A Canadian research team found that the radial artery outperformed the saphenous vein as the best conduit for coronary artery bypass graft (CABG) surgery. The radial artery also...